Without the bacteriostatic agent, once you puncture the stopper, the clock starts ticking
Dosing Recommendations While human clinical trial data remains limited, current evidence-based recommendations derived from animal studies and clinical experience suggest: General anti-inflammatory dosing: 200-500 mcg administered subcutaneously once daily or 500-1000 mcg twice weekly Acute injury management: Higher doses (500-1000 mcg) may be used daily initially, with tapering to maintenance doses Route of administration: Both systemic (subcutaneous/intramuscular) and local (perilesional) injections have shown similar efficacy
However, if the pain worsens after 1014 days, swelling doesnt improve, or they experience redness, warmth, fever, or signs of infection, patients should seek medical attention
The body determines where fat is stored and where it is lost based on factors such as: Genetics Hormones Age Overall body composition If someone loses weight while using BPC-157, there is no evidence suggesting the peptide specifically targets fat around the stomach